XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 15.31%, Johnson & Johnson at 8.64%, AbbVie at 7.11%, UnitedHealth Group at 5.13%, and Merck & Co. at 4.58%.

Total Holdings

Top 10 Percentage

58.08%

Asset Class

Equity

ETF Category

Health

Assets

40.40B

PE Ratio

22.53

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	15.31%	5,689,828
2	JNJ	Johnson & Johnson	8.64%	17,235,928
3	ABBV	AbbVie Inc.	7.11%	12,642,842
4	UNH	UnitedHealth Group Incorporated	5.13%	6,481,721
5	MRK	Merck & Co., Inc.	4.58%	17,876,055
6	TMO	Thermo Fisher Scientific Inc.	3.92%	2,702,476
7	ABT	Abbott Laboratories	3.87%	12,456,125
8	ISRG	Intuitive Surgical, Inc.	3.60%	2,565,522
9	AMGN	Amgen Inc.	3.19%	3,852,938
10	GILD	Gilead Sciences, Inc.	2.74%	8,880,159
11	BSX	Boston Scientific Corporation	2.61%	10,604,544
12	DHR	Danaher Corporation	2.55%	4,560,902
13	PFE	Pfizer Inc.	2.54%	40,690,307
14	MDT	Medtronic plc	2.34%	9,169,762
15	SYK	Stryker Corporation	2.24%	2,462,471
16	MCK	McKesson Corporation	1.92%	890,174
17	VRTX	Vertex Pharmaceuticals Incorporated	1.91%	1,834,915
18	BMY	Bristol-Myers Squibb Company	1.73%	14,567,201
19	CVS	CVS Health Corporation	1.73%	9,077,153
20	HCA	HCA Healthcare, Inc.	1.47%	1,172,247
21	REGN	Regeneron Pharmaceuticals, Inc.	1.39%	729,060
22	ELV	Elevance Health, Inc.	1.31%	1,611,567
23	CI	The Cigna Group	1.29%	1,910,363
24	COR	Cencora, Inc.	1.26%	1,387,557
25	IDXX	IDEXX Laboratories, Inc.	1.06%	572,582

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Nov 25, 2025